Japan’s Shionogi says COVID pill reaches Phase III milestone

TOKYO, Sept 28 (Reuters) – Japan’s Shionogi & Co Ltd (4507.T) said on Wednesday its oral treatment for COVID-19 demonstrated a significant reduction in symptoms compared with a placebo in…

Japan’s Shionogi seeks approval for COVID-19 pill

Passengers wearing protective face masks are seen inside a train, amid the coronavirus disease (COVID-19) pandemic, in Tokyo, Japan February 9, 2022. REUTERS/Issei Kato Register now for FREE unlimited access…